Published in Arthritis Res on September 24, 2002
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A (2006) 3.11
Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun (2009) 1.66
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol (2010) 1.43
Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf (2009) 1.33
Sjögren's syndrome: an old tale with a new twist. Arch Immunol Ther Exp (Warsz) (2009) 1.16
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther (2007) 1.16
Identification of specific autoantigens in Sjögren's syndrome by SEREX. Immunology (2005) 1.05
Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis. Clin Vaccine Immunol (2011) 1.03
Genes and Sjögren's syndrome. Rheum Dis Clin North Am (2008) 1.01
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life Sci (2008) 0.93
Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. Ann Rheum Dis (2010) 0.91
IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome. J Clin Immunol (2008) 0.88
The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice. Arthritis Res Ther (2007) 0.84
[Sjögren's syndrome. Current aspects from a rheumatological point of view]. Z Rheumatol (2006) 0.82
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease. Arthritis Res Ther (2014) 0.81
Aquaporin gene therapy corrects Sjögren's syndrome phenotype in mice. Proc Natl Acad Sci U S A (2016) 0.81
The association between TNF-α, IL-10 gene polymorphisms and primary Sjögren's syndrome: a meta-analysis and systemic review. PLoS One (2013) 0.78
Current Aspects of Pathogenesis in Sjögren's Syndrome. Ther Adv Musculoskelet Dis (2010) 0.78
Sexual dimorphism in an animal model of Sjögren's syndrome: a potential role for Th17 cells. Biol Open (2015) 0.77
Distinct dacryoadenitides autoadoptively transferred to rabbits by different subpopulations of lymphocytes activated ex vivo. Cornea (2010) 0.76
Like father, like son. Ann Rheum Dis (2007) 0.75
Cigarette smoking and the risk of primary Sjögren's syndrome: a nested case control study. Arthritis Res Ther (2017) 0.75
Juvenile dermatomyositis with Sjögren's syndrome. Clin Rheumatol (2007) 0.75
High-resolution HLA analysis of primary and secondary Sjögren's syndrome: a common immunogenetic background in Mexican patients. Rheumatol Int (2014) 0.75
Identification of a quantitative trait locus regulating B cell-dominant infiltration into autoimmune sialitis lesions of the IQI mouse model of primary Sjögren's syndrome. Immunogenetics (2007) 0.75
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A (1998) 3.35
Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels. J Biol Chem (1999) 2.91
Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A (1993) 2.81
Subcellular distribution of aquaporin 5 in salivary glands in primary Sjögren's syndrome. Lancet (2001) 2.28
Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome. Lancet (2001) 2.10
Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature (1989) 1.98
Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med (1993) 1.75
An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol (1999) 1.67
Monozygotic twins with primary Sjögren's syndrome. J Rheumatol (2000) 1.63
Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Arthritis Rheum (2002) 1.61
Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum (2001) 1.59
The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med (1993) 1.58
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum (1988) 1.47
Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients. Lab Invest (2001) 1.40
Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol (1996) 1.31
The HLA system and the analysis of multifactorial genetic disease. Trends Genet (1995) 1.28
Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome. Scand J Rheumatol (2000) 1.25
A novel NOD-derived murine model of primary Sjögren's syndrome. Arthritis Rheum (1998) 1.22
Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes. Eur J Immunol (2001) 1.16
Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A (1997) 1.15
Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity (2001) 1.15
Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy. J Rheumatol (2000) 1.13
IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol (1998) 1.12
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med (1984) 1.11
Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol (2002) 1.10
Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10. J Immunol (1999) 1.08
Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum (1989) 1.00
Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome. Arthritis Rheum (2001) 0.97
Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res (2001) 0.97
HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin Exp Immunol (1998) 0.97
Fas and Fas ligand gene polymorphisms in primary Sjögren's syndrome. J Rheumatol (2000) 0.96
HLA-D antigen frequencies in Sjögren's syndrome. Differences between the primary and secondary form. Scand J Rheumatol (1981) 0.94
HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome. J Rheumatol (2001) 0.94
Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome. Arthritis Rheum (1997) 0.93
Immunologically restricted and inhibitory anti-Ro/SSA in monozygotic twins. Lupus (1997) 0.93
HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjögren's syndrome. Rheumatology (Oxford) (2001) 0.92
The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol (1992) 0.92
Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J Immunol (1993) 0.91
The occurrence of various collagen diseases in one family: a sister with ISSc, PBC, APS, and SS and a brother with systemic lupus erythematosus. J Dermatol (2001) 0.90
Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum (1998) 0.90
Genetic susceptibility to the development of autoimmune disease. Clin Sci (Lond) (1997) 0.90
The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases. Clin Immunol Immunopathol (1996) 0.90
Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome. J Rheumatol (1997) 0.89
Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome. Scand J Immunol (1999) 0.88
Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis. Scand J Immunol (1997) 0.88
Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. Clin Exp Rheumatol (1998) 0.87
Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome. Lab Invest (2002) 0.87
Fas-induced apoptosis is a rare event in Sjögren's syndrome. Lab Invest (2001) 0.87
HLA class I and class II are both associated with the genetic predisposition to primary Sjögren syndrome. Hum Immunol (2001) 0.87
Association of HLA-DR7 with both antibody to SSA(Ro) and disease susceptibility in blacks with systemic lupus erythematosus. J Rheumatol (1984) 0.86
Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters. A family study. Am J Med (1983) 0.86
Selective down-regulation of aquaporin-1 in salivary glands in primary Sjögren's syndrome. Lab Invest (2002) 0.85
HLA-alloantigen associations in Greek patients with Sjögren's syndrome. J Autoimmun (1988) 0.85
52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart. J Exp Med (1995) 0.85
The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. Eur J Immunol (2002) 0.85
Chronic bilateral dacryo-adenitis in identical twins: a possible incomplete form of Sjögren syndrome. Eur J Pediatr (1991) 0.84
Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alterations in circulating T cell receptor gamma/delta subsets. Arthritis Rheum (1996) 0.83
Sjögren's syndrome and achalasia of the cardia in two siblings. Pediatrics (1973) 0.83
Associations of MHC class II alleles in Norwegian primary Sjögren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol (2001) 0.82
Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. Arthritis Rheum (1999) 0.82
Familial Sjögren's syndrome with associated primary salivary gland lymphoma. Am J Med (1976) 0.82
A multicase family with primary Sjögren's syndrome. J Rheumatol (2001) 0.81
Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation. Clin Exp Immunol (1999) 0.81
DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility. Clin Exp Rheumatol (1999) 0.81
Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren's syndrome and autoantibody production. J Clin Lab Anal (1991) 0.80
Immunoglobulin Vlambda light chain gene usage in patients with Sjögren's syndrome. Arthritis Rheum (2001) 0.80
Genetics of autoimmune disease. Curr Opin Immunol (1995) 0.80
MHC and autoimmune diseases. Immunol Ser (1993) 0.80
The role of apoptosis in Sjögren's syndrome. Ann Med Interne (Paris) (1998) 0.80
Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome. Arthritis Rheum (2002) 0.80
Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol (2002) 0.80
Light chain variable (VL) sequences of rheumatoid factors (RF) in patients with primary Sjögren's syndrome (pSS): moderate contribution of somatic hypermutation. Scand J Immunol (1999) 0.80
[Familiarity characteristics of Sjögren's disease. (Clinical contribution and considerations)]. Riv Crit Clin Med (1965) 0.79
Multiple immunological abnormalities in a family. J Clin Pathol (1971) 0.79
Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome. Scand J Immunol (2001) 0.79
Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome. J Rheumatol (2000) 0.79
[Identical twins of Sjörgren's syndrome with renal tubular acidosis (author's transl)]. Nihon Naika Gakkai Zasshi (1980) 0.77
The immunogenetics of Sjögren's syndrome. Rheum Dis Clin North Am (1992) 0.76
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet (2002) 4.03
Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum (2005) 2.21
Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis (2013) 2.21
Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann Rheum Dis (2011) 2.12
Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum (2003) 2.03
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet (2013) 1.79
High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome. Arthritis Rheumatol (2015) 1.57
Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome. Arthritis Rheumatol (2014) 1.53
Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. J Infect Dis (2002) 1.48
Sjögren's syndrome. Eur J Oral Sci (2005) 1.46
Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands. Nat Genet (2005) 1.43
Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren's syndrome. J Clin Immunol (2005) 1.38
Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther (2008) 1.29
Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog (2013) 1.22
Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol (2007) 1.21
Sjögren's syndrome: studying the disease in mice. Arthritis Res Ther (2011) 1.21
Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum (2004) 1.18
Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2007) 1.17
Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol (2005) 1.16
The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J Biol Chem (2010) 1.15
Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. Autoimmun Rev (2011) 1.12
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med (2013) 1.12
Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford) (2009) 1.08
Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration. Clin Immunol (2002) 1.06
New concepts in the pathogenesis of Sjögren's syndrome. Rheum Dis Clin North Am (2008) 1.05
Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome. Arthritis Rheum (2003) 0.96
Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome. J Immunol (2005) 0.96
Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol (2003) 0.95
Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome. Lab Invest (2003) 0.94
Animal models of Sjögren's syndrome. Clin Rev Allergy Immunol (2007) 0.94
Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum (2008) 0.94
Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther (2011) 0.93
Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. Ann Rheum Dis (2010) 0.91
Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples. Ann Rheum Dis (2012) 0.90
Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF. J Clin Immunol (2004) 0.88
Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome. Lab Invest (2002) 0.87
Differential cytokine response in interstitial fluid in skin and serum during experimental inflammation in rats. J Physiol (2004) 0.86
Genetic associations to germinal centre formation in primary Sjogren's syndrome. Ann Rheum Dis (2013) 0.86
Selective down-regulation of aquaporin-1 in salivary glands in primary Sjögren's syndrome. Lab Invest (2002) 0.85
Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome. Scand J Immunol (2013) 0.85
The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. Eur J Immunol (2002) 0.85
A five-year prospective study of fatigue in primary Sjögren's syndrome. Arthritis Res Ther (2011) 0.85
Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses. BMC Immunol (2011) 0.84
The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice. Arthritis Res Ther (2007) 0.84
Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study. Arthritis Care Res (Hoboken) (2013) 0.83
The long-term effect of anti TNF-alpha treatment on temporomandibular joints, oral mucosa, and salivary flow in patients with active rheumatoid arthritis: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.83
Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome. Ann Rheum Dis (2009) 0.83
Potential association of muscarinic receptor 3 gene variants with primary Sjogren's syndrome. Ann Rheum Dis (2011) 0.83
The bacterial preparation OK432 induces IL-12p70 secretion in human dendritic cells in a TLR3 dependent manner. PLoS One (2012) 0.81
Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome. Arthritis Res Ther (2014) 0.81
A prospective study of sicca symptoms in patients with rheumatoid arthritis. Arthritis Rheum (2003) 0.81
Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome. Presse Med (2012) 0.81
Carbamylation of immunoglobulin abrogates activation of the classical complement pathway. Eur J Immunol (2014) 0.81
The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis. J Neuroimmunol (2006) 0.81
Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study. Scand J Rheumatol (2002) 0.80
Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue's extracellular milieu precede immune responses in Sjögren's syndrome. Arthritis Res Ther (2013) 0.80
Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Lab Invest (2003) 0.80
A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study. Rheumatol Int (2013) 0.80
An experimental protocol for the fractionation and 2DE separation of HeLa and A-253 cell lysates suitable for the identification of the individual antigenic proteome in Sjögren's syndrome. Autoimmunity (2011) 0.79
Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome. Eur J Immunol (2005) 0.79
In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome. Arthritis Res Ther (2013) 0.79
Implications of long-term medication of oral steroids and antimalarial drugs in primary Sjögren's syndrome. Int Immunopharmacol (2011) 0.79
Glutaminyl cyclases as novel targets for the treatment of septic arthritis. J Infect Dis (2012) 0.78
Levels of dendritic cell populations and regulatory T cells vary significantly between two commonly used mouse strains. Scand J Immunol (2009) 0.78
Distinct phenotypes of plasma cells in spleen and bone marrow of autoimmune NOD.B10.H2b mice. Autoimmunity (2011) 0.78
Dietary nucleotides and human immune cells. II. Modulation of PBMC growth and cytokine secretion. Nutrition (2006) 0.78
Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome. Autoimmunity (2012) 0.77
Gene therapeutics in Sjögren's syndrome. Expert Opin Biol Ther (2005) 0.77
Aquaporins in primary Sjögren's syndrome: comment on the articles by Steinfeld et al. Arthritis Rheum (2003) 0.77
CD11c(+) dendritic cells rather than Langerhans cells are reduced in normal skin of immunosuppressed renal transplant recipients. Acta Derm Venereol (2014) 0.76
The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab. BMC Musculoskelet Disord (2014) 0.76
Göran Möller 1936-2008. Scand J Immunol (2008) 0.76
Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice. Arthritis Res Ther (2008) 0.75
Polymyalgia rheumatica in primary Sjögren's syndrome. Rheumatol Int (2005) 0.75
Quantification of plasmacytoid dendritic cells and type 1 myeloid dendritic cells in peripheral blood of renal transplant recipients with and without squamous cell carcinoma. Acta Derm Venereol (2012) 0.75
The Nobel prize in physiology or medicine 2005. Scand J Immunol (2005) 0.75
2011 Nobel Prize in Physiology or Medicine to three immunologists. Scand J Immunol (2011) 0.75
The Nobel prize in physiology or medicine for 2008. Scand J Immunol (2008) 0.75
Retraction. Scand J Immunol (2009) 0.75
Dietary nucleotides and human immune cells. II. Modulation of PBMC growth and cytokine secretion. Nutrition (2005) 0.75
The Nobel Prize in Chemistry for 2003. Scand J Immunol (2003) 0.75
Minor changes in serum levels of cytokines after removal of amalgam restorations. Toxicol Lett (2012) 0.75